S178: SAFETY AND EFFICACY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH RD IN NEWLY DIAGNOSED, TRANSPLANT INELIGIBLE MULTIPLE MYELOMA PATIENTS: A PHASE 1/2 STUDY BY THE HELLENIC SOCIETY OF HEMATOLOGY
E. Terpos,
M. Gavriatopoulou,
I. Ntanasis-Stathopoulos,
P. Malandrakis,
D. Fotiou,
N. Kanellias,
S. Gkolfinopoulos,
K. Manousou,
E. Kastritis,
M.-A. Dimopoulos
Affiliations
E. Terpos
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
M. Gavriatopoulou
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
I. Ntanasis-Stathopoulos
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
P. Malandrakis
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
D. Fotiou
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
N. Kanellias
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
S. Gkolfinopoulos
2 Health Data Specialists, Dublin, Ireland
K. Manousou
2 Health Data Specialists, Dublin, Ireland
E. Kastritis
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
M.-A. Dimopoulos
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
